Forte Biosciences, Inc. · NASDAQ:FBRX
Orbimed Advisors LLC's stake in Forte Biosciences, Inc. fell below 5% (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
Orbimed Advisors LLC's stake in Forte Biosciences, Inc. fell below 5%, 0 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ORBIMED ADVISORS LLC | 0% | 0 |
| OrbiMed Capital GP IX LLC | 0% | 0 |
| ORBIMED CAPITAL LLC | 0% | 0 |
Source
Download original · View original at SEC
Related
- Forte Biosciences, Inc.
- Orbimed Advisors LLC
- Forte Biosciences, Inc. shareholders
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Orbimed Advisors LLC · May 15, 2026
- Schedule 13G · Orbimed Advisors LLC · Feb 14, 2025
- Schedule 13G/A · Glazer Capital, LLC · Nov 16, 2026
- Schedule 13G/A · Mpm Bioimpact LLC · Nov 13, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Nov 13, 2026
- Schedule 13G/A · Tybourne Capital Management (Hk) LTD · Nov 4, 2026
- Schedule 13G/A · Federated Hermes, Inc. · Sep 8, 2026